Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns
- Conditions
- Hemodynamics
- Interventions
- Procedure: Goal-directed hemodynamic therapy
- Registration Number
- NCT05221788
- Lead Sponsor
- Guangzhou Red Cross Hospital
- Brief Summary
To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.
- Detailed Description
Objective: To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.
Methods: Ninety-five patients with extensive burns undergoing early debridement grafting were randomly divided into a standard hemodynamic management group (control group) and a goal-directed hemodynamic therapy group (GDHT group), with the control group guided by conventional parameters and the GDHT group guided by SV based on Vigileo. The primary outcome were incidence of cardiac complications, pulmonary complications, neurological disease, acute kidney injury, and pain within 7 days postoperatively. Secondary outcome included microcirculatory perfusion metrics: Lactate (lac), The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- the age is between 18 and 65 years old;
- the burn area ≥ 50% total burn surface area (TBSA) or the third degree wound area ≥ 20% TBSA;
- patients will undergo the first operation after fluid resuscitation (after the shock period). The types of operation include incision decompression, escharectomy and skin grafting, and so on.
- Severe cardiac or pulmonary disease prior to the burn injury, combined with severe internal organ damage.
- Patients or family members refusing informed consent for this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description GDHT(goal-directed hemodynamic therapy) Goal-directed hemodynamic therapy Compounded sodium lactate 3 ml/kg/h was given intravenously as a basal rehydration volume before induction, and 200 ml of electrolyte solution was given after induction. If stroke volume (SV) increased \>10%, 200 ml of electrolyte solution was continued until SV increased \<10%. After fluid shock, if SV increases \<10% but MAP \<65 mmHg and/or cardiac index (CI) \<2.5l/min/m2 give low-dose norepinephrine continuous pumping and/or dobutamine continuous pumping. If hypotension was accompanied by hypovolemia (defined as urine output \<0.5 ml /kg/h and/or heart rate (HR) more than 20% above baseline), plasma was administered until urine output and/or heart rate returned to normal. Fluid responsiveness and hemodynamic variables were reassessed at least every 15 minutes, and more frequently in cases of hemodynamic instability.
- Primary Outcome Measures
Name Time Method Incidence of pulmonary complications within 7 days postoperatively Incidence of pulmonary complications (pneumonia, pulmonary edema, pleural effusion, oxygenation index \<300)
Incidence of cardiac complications within 7 days postoperatively Incidence of cardiac complications within 7 days of surgery (myocardial infarction (electrocardiogram (ECG) and/or troponin T serum concentration; new-onset atrial fibrillation)
postoperative pain conditions within 7 days postoperatively postoperative pain
Incidence of neurological complications within 7 days postoperatively Incidence of Neurological Disorders within 7 days postoperatively (Stroke and Delirium)
Incidence of acute kidney injury within 7 days postoperatively defined by acute kidney injury criteria.
- Secondary Outcome Measures
Name Time Method Blood lactate 7 days after operation an indicator related to microcirculation perfusion
Blood lacate 2 hours into the operation (T3) an indicator related to microcirculation perfusion
The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2) 7 days after operation an indicator related to microcirculation perfusion
Trial Locations
- Locations (1)
Guangzhou RedCross Hospital
🇨🇳Guanzhou, Guangdong, China